Onno B. Bleijerveld

The Netherlands Cancer Institute — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index2.6kcitations110works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ubiquitin and proteasome pathways(18), Fibroblast Growth Factor Research(16), Advanced Proteomics Techniques and Applications(11), RNA modifications and cancer(11), Hippo pathway signaling and YAP/TAZ(11)

Publications110 total

MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation
Communications Biology·2026Open Access
<i>DEprot</i> : a comprehensive R-package for the analysis of label-free quantitation mass spectrometry data
NAR Genomics and Bioinformatics·2026Open Access
Identification of mono-ADP-ribose readers using well-defined photoaffinity-based probes
RSC Chemical Biology·2025Open Access
Author response for "Identification of Mono-ADP-Ribose Readers Using Well-Defined Photoaffinity-based Probes"
2025
Integrating computational protein structure predictions and genetic dependencies yields an atlas of human multi-protein complexes (AHMPC)
2025Open Access
Supplementary Figure S1 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Figure S7 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Figure S8 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Figure S6 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Data from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Figure S4 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Table S3 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Figure S3 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Figure S2 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Figure S5 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Methods from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Figure S9 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Table S1 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Table S2 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
Supplementary Table S4 from The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2
2025Open Access
page 1 of 6Next →

Frequent Co-authors

Maarten Altelaar(21), Liesbeth Hoekman(12), Reuven Agami(11), Thijn R. Brummelkamp(7), Abhijeet Pataskar(7), Daniel S. Peeper(7), Albert J. R. Heck(7), Remco Nagel(6), Julien Champagne(6), Arjen Scholten(6), Maaike Kreft(6), Joppe Nieuwenhuis(5), Anastassis Perrakis(5), Jasmine Montenegro Navarro(5), Arnoud Sonnenberg(5), Mark Roest(4), Ji‐Ying Song(4), Alba Zuidema(4), Yuval Malka(4), Athanassios Adamopoulos(3)